investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Structural and Functional Studies of Tumor Suppressor Proteins PALB2 and BRCA2
Sergey Korolev
1 Collaborator(s)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Jean-Yves Masson
Laval University
Québec, Canada
Laval University Cancer Research Center
Québec, Canada
Sergey Korolev
Saint Louis University
St Louis, United States
Related projects
Thangaiyan Rabi
Novel Oleanane Triterpenoid AMR-MeOAc for Breast Cancer Prevention and Therapy
Breast
Carol Prives
Roles and Regulation of p53
Breast
Targeted Epigenetic Therapy of Triple-Negative Breast Cancer
Breast
C Marcelo Aldaz
Characterization of WWOX, the Cancer Gene Spanning FRA16D
Breast
Dihua Yu
Stromal activation in the progression of high ErbB2/1433zeta DCIS to IBC
Breast
Shyam Sharan
Functional Analysis of Human Breast Cancer Susceptibility Gene Variants
Breast
Junjie Chen
Analysis of BRCA1 function in DNA Repair
Breast
Kuo-Hsiung Lee
Novel Antitumor Agents
Breast
Fraser Symmans
Development of A Predictive Genomic Diagnostic Test for Survival Benefit from Everolimus (mTOR Inhibitor) Combined with Endocrine Therapy for Metastatic HR+/HER- Breast Cancer
Breast